IQVIAIQVEarnings & Financial Report
IQVIA Holdings, Inc., headquartered in Durham, North Carolina, is an American company focused on health information technology and clinical research.
Revenue
$3.8B
Gross Profit
$863.0M
Operating Profit
$520.0M
Net Profit
$363.0M
Gross Margin
22.6%
Operating Margin
13.6%
Net Margin
9.5%
YoY Growth
2.3%
EPS
$1.97
IQVIA Q2 FY2024 Financial Summary
IQVIA reported revenue of $3.8B (up 2.3% YoY) for Q2 FY2024, with a net profit of $363.0M (up 22.2% YoY) (9.5% margin). Cost of goods sold was $3.0B, operating expenses totaled $343.0M.
Key Financial Metrics
| Total Revenue | $3.8B |
|---|---|
| Net Profit | $363.0M |
| Gross Margin | 22.6% |
| Operating Margin | 13.6% |
| Report Period | Q2 FY2024 |
Revenue Breakdown
IQVIA Q2 FY2024 revenue of $3.8B breaks down across 4 segments, led by Other at $2.0B (51.2% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Other | $2.0B | 51.2% |
| Research And Development Solutions | $1.0B | 26.6% |
| Technology And Analytics Solutions | $783.0M | 20.5% |
| Contract Sales And Medical Solutions | $66.0M | 1.7% |
IQVIA Revenue by Segment — Quarterly Trend
IQVIA revenue by segment across the last 4 reported quarters, showing how each business line (such as Other and Research And Development Solutions) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Other | — | — | $2.2B | $2.1B |
| Research And Development Solutions | — | — | $1.0B | $1.0B |
| Technology And Analytics Solutions | — | — | $824.0M | $830.0M |
| Contract Sales And Medical Solutions | — | — | $70.0M | $68.0M |
IQVIA Annual Revenue by Year
IQVIA annual revenue history includes year-by-year totals (for example, 2025 revenue was $16.3B).
| Year | Annual Revenue |
|---|---|
| 2025 | $16.3B |
| 2024 | $15.4B |
IQVIA Quarterly Revenue & Net Profit History
IQVIA results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $4.2B | +8.4% | $275.0M | 6.6% |
| Q4 FY2025 | $4.4B | +10.3% | $514.0M | 11.8% |
| Q3 FY2025 | $4.1B | +5.2% | $331.0M | 8.1% |
| Q2 FY2025 | $4.0B | +5.3% | $266.0M | 6.6% |
| Q1 FY2025 | $3.8B | +2.5% | $249.0M | 6.5% |
| Q4 FY2024 | $4.0B | +2.3% | $437.0M | 11.0% |
| Q3 FY2024 | $3.9B | +4.3% | $285.0M | 7.3% |
| Q2 FY2024 | $3.8B | +2.3% | $363.0M | 9.5% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.81B | $3.90B | $3.96B | $3.83B | $4.02B | $4.10B | $4.36B | $4.15B |
| YoY Growth | 2.3% | 4.3% | 2.3% | 2.5% | 5.3% | 5.2% | 10.3% | 8.4% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $26.40B | $27.18B | $26.90B | $27.32B | $28.63B | $28.73B | $29.94B | $29.68B |
| Liabilities | $19.68B | $20.21B | $20.83B | $21.34B | $22.85B | $22.44B | $23.31B | $23.33B |
| Equity | $6.71B | $6.97B | $6.07B | $5.98B | $5.78B | $6.16B | $6.50B | $6.35B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $588.0M | $721.0M | $885.0M | $568.0M | $443.0M | $908.0M | $735.0M | $618.0M |